Titre : Surdité mixte de transmission et neurosensorielle

Surdité mixte de transmission et neurosensorielle : Questions médicales fréquentes

Termes MeSH sélectionnés :

Gene Expression Profiling
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Surdité mixte de transmission et neurosensorielle : Questions médicales les plus fréquentes", "headline": "Surdité mixte de transmission et neurosensorielle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Surdité mixte de transmission et neurosensorielle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-23", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Surdité mixte de transmission et neurosensorielle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Perte d'audition", "url": "https://questionsmedicales.fr/mesh/D034381", "about": { "@type": "MedicalCondition", "name": "Perte d'audition", "code": { "@type": "MedicalCode", "code": "D034381", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.763.393.341" } } }, "about": { "@type": "MedicalCondition", "name": "Surdité mixte de transmission et neurosensorielle", "alternateName": "Hearing Loss, Mixed Conductive-Sensorineural", "code": { "@type": "MedicalCode", "code": "D046089", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Andrea Canale", "url": "https://questionsmedicales.fr/author/Andrea%20Canale", "affiliation": { "@type": "Organization", "name": "ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy." } }, { "@type": "Person", "name": "Valerio Bordino", "url": "https://questionsmedicales.fr/author/Valerio%20Bordino", "affiliation": { "@type": "Organization", "name": "ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy." } }, { "@type": "Person", "name": "Andrea Albera", "url": "https://questionsmedicales.fr/author/Andrea%20Albera", "affiliation": { "@type": "Organization", "name": "ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy." } }, { "@type": "Person", "name": "Anastasia Urbanelli", "url": "https://questionsmedicales.fr/author/Anastasia%20Urbanelli", "affiliation": { "@type": "Organization", "name": "ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy." } }, { "@type": "Person", "name": "Maria Gragnano", "url": "https://questionsmedicales.fr/author/Maria%20Gragnano", "affiliation": { "@type": "Organization", "name": "Department of Public Health Sciences and Paediatrics, University of Turin, Turin, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Expression Profile of Inflammation Response Genes and Potential Regulatory Mechanisms in Dilated Cardiomyopathy.", "datePublished": "2022-08-17", "url": "https://questionsmedicales.fr/article/36035223", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/1051652" } }, { "@type": "ScholarlyArticle", "name": "An interferon-inducible signature of airway disease from blood gene expression profiling.", "datePublished": "2022-05-19", "url": "https://questionsmedicales.fr/article/34649980", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1183/13993003.00569-2021" } }, { "@type": "ScholarlyArticle", "name": "Genome-Wide Analysis and Expression Profiling of Glutathione Reductase Gene Family in Oat (", "datePublished": "2022-10-01", "url": "https://questionsmedicales.fr/article/36232950", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms231911650" } }, { "@type": "ScholarlyArticle", "name": "Genome-Wide Analysis and Expression Profiling of the Phenylalanine Ammonia-Lyase Gene Family in", "datePublished": "2022-06-20", "url": "https://questionsmedicales.fr/article/35743276", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms23126833" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiles and metabolic pathways responsible for male sterility in cybrid pummelo.", "datePublished": "2024-10-15", "url": "https://questionsmedicales.fr/article/39407042", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00299-024-03357-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations neurologiques", "item": "https://questionsmedicales.fr/mesh/D009461" }, { "@type": "ListItem", "position": 5, "name": "Troubles sensitifs", "item": "https://questionsmedicales.fr/mesh/D012678" }, { "@type": "ListItem", "position": 6, "name": "Troubles de l'audition", "item": "https://questionsmedicales.fr/mesh/D006311" }, { "@type": "ListItem", "position": 7, "name": "Perte d'audition", "item": "https://questionsmedicales.fr/mesh/D034381" }, { "@type": "ListItem", "position": 8, "name": "Surdité mixte de transmission et neurosensorielle", "item": "https://questionsmedicales.fr/mesh/D046089" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Surdité mixte de transmission et neurosensorielle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Surdité mixte de transmission et neurosensorielle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Surdité mixte de transmission et neurosensorielle", "description": "Comment diagnostiquer la surdité mixte ?\nQuels examens sont nécessaires ?\nQuels signes indiquent une surdité mixte ?\nPeut-on détecter la surdité mixte chez les enfants ?\nQuel spécialiste consulte-t-on pour ce diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Gene+Expression+Profiling&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Surdité mixte de transmission et neurosensorielle", "description": "Quels sont les symptômes de la surdité mixte ?\nLa surdité mixte cause-t-elle des douleurs ?\nY a-t-il des signes d'alerte ?\nLes enfants montrent-ils des symptômes différents ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Gene+Expression+Profiling&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Surdité mixte de transmission et neurosensorielle", "description": "Comment prévenir la surdité mixte ?\nLes protections auditives sont-elles utiles ?\nFaut-il éviter certains médicaments ?\nLes examens réguliers sont-ils nécessaires ?\nL'éducation sur la santé auditive est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Gene+Expression+Profiling&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Surdité mixte de transmission et neurosensorielle", "description": "Quels traitements sont disponibles ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une chirurgie ?\nLes appareils auditifs sont-ils efficaces ?\nY a-t-il des thérapies alternatives ?", "url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Gene+Expression+Profiling&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Surdité mixte de transmission et neurosensorielle", "description": "Quelles complications peuvent survenir ?\nLa surdité mixte peut-elle affecter la qualité de vie ?\nY a-t-il des risques de dépression ?\nLes complications sont-elles réversibles ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Gene+Expression+Profiling&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Surdité mixte de transmission et neurosensorielle", "description": "Quels sont les facteurs de risque ?\nL'âge est-il un facteur de risque ?\nLes maladies chroniques influencent-elles ?\nLes traumatismes crâniens sont-ils un risque ?\nLes infections de l'oreille sont-elles un facteur ?", "url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Gene+Expression+Profiling&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la surdité mixte ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un audiogramme et des tests d'imagerie sont utilisés pour évaluer la perte auditive." } }, { "@type": "Question", "name": "Quels examens sont nécessaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des examens cliniques, audiométriques et parfois une IRM sont nécessaires." } }, { "@type": "Question", "name": "Quels signes indiquent une surdité mixte ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des difficultés à entendre dans des environnements bruyants et des sons étouffés." } }, { "@type": "Question", "name": "Peut-on détecter la surdité mixte chez les enfants ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests auditifs peuvent être réalisés dès la naissance pour détecter cette condition." } }, { "@type": "Question", "name": "Quel spécialiste consulte-t-on pour ce diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un oto-rhino-laryngologiste (ORL) est le spécialiste à consulter pour ce diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes de la surdité mixte ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent une perte auditive variable, des acouphènes et des difficultés de compréhension." } }, { "@type": "Question", "name": "La surdité mixte cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut causer des douleurs si des infections de l'oreille sont présentes." } }, { "@type": "Question", "name": "Y a-t-il des signes d'alerte ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des difficultés soudaines à entendre ou des bruits étranges peuvent être des signes d'alerte." } }, { "@type": "Question", "name": "Les enfants montrent-ils des symptômes différents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent avoir des retards de langage ou des difficultés scolaires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégénérescence." } }, { "@type": "Question", "name": "Comment prévenir la surdité mixte ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les bruits forts, traiter rapidement les infections de l'oreille et faire des bilans auditifs réguliers." } }, { "@type": "Question", "name": "Les protections auditives sont-elles utiles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles protègent contre les dommages auditifs dans des environnements bruyants." } }, { "@type": "Question", "name": "Faut-il éviter certains médicaments ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments ototoxiques doivent être évités pour prévenir des dommages auditifs." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils nécessaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens auditifs réguliers aident à détecter précocement des problèmes auditifs." } }, { "@type": "Question", "name": "L'éducation sur la santé auditive est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sensibiliser à la santé auditive aide à prévenir des pertes auditives futures." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des appareils auditifs, des implants cochléaires et des interventions chirurgicales." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être prescrits pour traiter des infections ou des inflammations associées." } }, { "@type": "Question", "name": "Quand envisager une chirurgie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée si des anomalies structurelles causent la perte auditive." } }, { "@type": "Question", "name": "Les appareils auditifs sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils améliorent souvent la capacité d'écoute, surtout dans des environnements calmes." } }, { "@type": "Question", "name": "Y a-t-il des thérapies alternatives ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines thérapies alternatives peuvent aider, mais leur efficacité n'est pas toujours prouvée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles de l'équilibre, des infections récurrentes et des difficultés sociales." } }, { "@type": "Question", "name": "La surdité mixte peut-elle affecter la qualité de vie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des problèmes de communication et d'interaction sociale." } }, { "@type": "Question", "name": "Y a-t-il des risques de dépression ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la perte auditive peut augmenter le risque de dépression et d'anxiété." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être traitées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une prise en charge multidisciplinaire est souvent nécessaire pour gérer les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des infections fréquentes et l'exposition au bruit." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement augmente le risque de surdité mixte en raison de la dégénérescence auditive." } }, { "@type": "Question", "name": "Les maladies chroniques influencent-elles ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète peuvent augmenter le risque de perte auditive." } }, { "@type": "Question", "name": "Les traumatismes crâniens sont-ils un risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes crâniens peuvent endommager les structures auditives et provoquer une surdité." } }, { "@type": "Question", "name": "Les infections de l'oreille sont-elles un facteur ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections récurrentes peuvent endommager l'oreille moyenne et interne, augmentant le risque." } } ] } ] }

Sources (10000 au total)

Expression Profile of Inflammation Response Genes and Potential Regulatory Mechanisms in Dilated Cardiomyopathy.

The inflammatory response is important in dilated cardiomyopathy (DCM). However, the expression of inflammatory response genes (IRGs) and regulatory mechanisms in DCM has not been well characterized.... We analyzed 27,665 cells of single-cell RNA sequencing dataset of four DCM samples and two healthy controls (HC). IRGs among differentially expressed genes (DEGs) of active cell clusters were screened... The proportions of dendritic cells (DCs), B cells, NK cells, and T cells were increased in DCM patients, whereas monocytes were decreased. DCs expressed more IRGs in DCM. The GO and KEGG analyses indi... DCs infiltrate into the myocardium and contribute to the immune response in DCM. The transcription factor ETS1 plays an important role in regulation of IRGs. Moreover,...

An interferon-inducible signature of airway disease from blood gene expression profiling.

The molecular basis of airway remodelling in chronic obstructive pulmonary disease (COPD) remains poorly understood. We identified gene expression signatures associated with chest computed tomography ... In 2396 subjects in the COPDGene Study, we examined the relationship between quantitative CT airway phenotypes and blood transcriptomes to identify airway disease-specific genes and to define an airwa... Type 1 interferon (IFN)-induced genes were consistently associated with AWT, square root wall area of a hypothetical airway with 10 mm internal perimeter (Pi10) and wall area percentage, with the stro... A gene expression signature with IFN-stimulated genes from peripheral blood and bronchial brushings is associated with CT AWT, lung function and exacerbations. Shared genes and genetic associations su...

Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma.

To validate the prognostic usefulness of gene expression profile (GEP) testing in patients with uveal melanoma. To determine whether combining tumor size with the GEP classification provides additiona... Retrospective analysis.... Patients with a diagnosis of choroidal melanoma examined at Yale New Haven Hospital; University of California, San Diego; and Memorial Sloan Kettering Cancer Center.... Patients' demographic and clinical data and tumor characteristics were collected. Univariate and multivariate Cox hazard regression analysis were used to assess the association between tumor character... Metastasis-free survival (MFS).... Of the 337 individuals included in the study, 87 demonstrated metastases. The mean follow-up time was 37.2 (standard deviation [SD], 40.2) months for patients with metastases and 55.0 (SD, 49.3) month... Tumor size was the most significant predictor of metastasis and provided additional prognostic value independent of GEP classification. In addition, rates of metastasis for class 2 tumors were lower t... The author(s) have no proprietary or commercial interest in any materials discussed in this article....

Autoimmune gene expression profiling of fingerstick whole blood in Chronic Fatigue Syndrome.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating condition that can lead to severe impairment of physical, psychological, cognitive, social, and occupational functions. Th... In 2021, one-hundred and sixty-six (166) patients diagnosed with ME/CFS and 83 healthy controls in the US participated in this study via a social media-based application (app). The patients and heathy... Among the 166 ME/CFS participants in the study, approximately half (49%) of the ME/CFS patients reported being house-bound or bedridden due to severe symptoms of the disease. From the AIP testing, ME/... Our study indicates that gene expression biomarkers may be used in identifying or differentiating subsets of ME/CFS patients having different levels of disease severity. These gene targets may also re...